Market Overview:
The global multiplexed diagnostics market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for advanced diagnostic tests, rising prevalence of chronic diseases, and growing investments in life sciences research. Based on type, the global multiplexed diagnostics market is segmented into very high density (VHD), high density (HD), medium density (MD), low density (LD), and next generation sequencing assays (NGS). The VHD segment is expected to account for the largest share of the global multiplexed diagnostics market in 2018. This large share can be attributed to the increasing demand for advanced diagnostic tests that offer higher throughput and accuracy. Based on application, the global multiplexed diagnostics market is segmented into academic research institutes, hospitals, pharmaceuticals companies, clinical research organizations, and diagnostic laboratories. The hospitals segment is expected to account for the largest share of this market in 2018 owing to rising demand for accurate diagnosis and treatment of various diseases.
Product Definition:
Multiplexed diagnostics is a technology that allows for the simultaneous detection of multiple biomarkers in a single assay. This technology is important because it can reduce the time required to detect and diagnose diseases.
Very High Density:
The global very high density (VHD) market size was valued at USD 4.5 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing demand for multiplexed diagnostics, which can be attributed to its cost-effectiveness as compared to conventional methods along with technological advancements are some of the major factors driving growth in this sector over the forecast period.
High Density:
High density is a type of genetic testing that helps in determining the chances of two people having similar DNA. It is also used for identifying hereditary diseases and medical conditions. The test works by comparing the DNA from two samples to determine if they match or not. This can be easily done with the help of a simple blood draw at an outpatient clinic, hospital or even at home using kits provided by companies such as 23andMe Inc., Myriad Genetics and others.
Application Insights:
The academic research institutes application segment dominated the market in 2017. This can be attributed to factors such as increasing government funding for R&D activities and an increase in number of research projects related to multiple myeloma, breast cancer, prostate cancer, melanoma skin cancer and other cancers. In addition, a rise in mergers & acquisitions among diagnostic laboratories has also positively impacted the growth of this segment. For instance, on March 21st 2018 Illumina announced that it had acquired Genome Institute Inc., a provider of genetic testing services for medical diagnostics products used by clinicians at academic institutions and hospitals worldwide. Such acquisition strategies are expected to drive the growth of this segment over the forecast period.
The hospital application is anticipated to witness lucrative growth during the study period owing to factors such as an increase in patient admissions due to COVID-19 pandemic across various regions including North America.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increasing investments in R&D, and high adoption rate for advanced technologies. Moreover, growing focus on quality healthcare services by government agencies is expected to drive the demand for medical diagnostics across this region. For instance, according to statistics published by National Cancer Institute (NCI), about 1 million new cases will be diagnosed annually over 20 years period between 2016 and 2025.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with improving healthcare infrastructure & facilities especially in developing countries such as India and China along with other South East Asian nations.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. The multiplexed diagnostics market is expected to benefit from this trend as it offers a more efficient and cost-effective way to detect and diagnose various chronic diseases.
- Rising demand for personalized medicine: A growing number of patients are now demanding customized or personalized medicines according to their specific needs and requirements. The multiplexed diagnostics market can play a key role in meeting this rising demand by offering more accurate and reliable diagnostic tests.
- Advances in technology: Technological advances are constantly taking place in the field of diagnostics, which is helping to improve the accuracy, speed, and efficiency of diagnostic tests offered by the multiplexed diagnostics market. This is likely to result in increased adoption rates for these products among healthcare providers worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Multiplexed Diagnostics Market Research Report
By Type
Very High Density, High Density, Medium Density, Low Density, Next Generation Sequencing Assays
By Application
Academic Research Institutes, Hospitals, Pharmaceuticals Companies, Clinical Research Organizations, Diagnostic Laboratories
By Companies
Agilent Technologies, Bio-Rad Laboratories, BioMérieux, Hoffmann-La Roche, Illumina, Luminex, Hologic, Thermo Fisher Scientific, Siemens Healthineers, Abbott
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Multiplexed Diagnostics Market Report Segments:
The global Multiplexed Diagnostics market is segmented on the basis of:
Types
Very High Density, High Density, Medium Density, Low Density, Next Generation Sequencing Assays
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Research Institutes, Hospitals, Pharmaceuticals Companies, Clinical Research Organizations, Diagnostic Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Agilent Technologies
- Bio-Rad Laboratories
- BioMérieux
- Hoffmann-La Roche
- Illumina
- Luminex
- Hologic
- Thermo Fisher Scientific
- Siemens Healthineers
- Abbott
Highlights of The Multiplexed Diagnostics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Very High Density
- High Density
- Medium Density
- Low Density
- Next Generation Sequencing Assays
- By Application:
- Academic Research Institutes
- Hospitals
- Pharmaceuticals Companies
- Clinical Research Organizations
- Diagnostic Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Multiplexed Diagnostics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Multiplexed diagnostics is a technology that allows for the simultaneous detection of multiple diseases or conditions in a single test. This can be helpful in reducing the time it takes to diagnosis and potentially providing more accurate results.
Some of the major players in the multiplexed diagnostics market are Agilent Technologies, Bio-Rad Laboratories, BioMƒÂ©rieux, Hoffmann-La Roche, Illumina, Luminex, Hologic, Thermo Fisher Scientific, Siemens Healthineers, Abbott.
The multiplexed diagnostics market is expected to register a CAGR of 10.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Multiplexed Diagnostics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Multiplexed Diagnostics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Multiplexed Diagnostics Market - Supply Chain
4.5. Global Multiplexed Diagnostics Market Forecast
4.5.1. Multiplexed Diagnostics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Multiplexed Diagnostics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Multiplexed Diagnostics Market Absolute $ Opportunity
5. Global Multiplexed Diagnostics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Multiplexed Diagnostics Market Size and Volume Forecast by Type
5.3.1. Very High Density
5.3.2. High Density
5.3.3. Medium Density
5.3.4. Low Density
5.3.5. Next Generation Sequencing Assays
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Multiplexed Diagnostics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Multiplexed Diagnostics Market Size and Volume Forecast by Application
6.3.1. Academic Research Institutes
6.3.2. Hospitals
6.3.3. Pharmaceuticals Companies
6.3.4. Clinical Research Organizations
6.3.5. Diagnostic Laboratories
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Multiplexed Diagnostics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Multiplexed Diagnostics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Multiplexed Diagnostics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Multiplexed Diagnostics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Multiplexed Diagnostics Demand Share Forecast, 2019-2026
9. North America Multiplexed Diagnostics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Multiplexed Diagnostics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Multiplexed Diagnostics Market Size and Volume Forecast by Application
9.4.1. Academic Research Institutes
9.4.2. Hospitals
9.4.3. Pharmaceuticals Companies
9.4.4. Clinical Research Organizations
9.4.5. Diagnostic Laboratories
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Multiplexed Diagnostics Market Size and Volume Forecast by Type
9.7.1. Very High Density
9.7.2. High Density
9.7.3. Medium Density
9.7.4. Low Density
9.7.5. Next Generation Sequencing Assays
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Multiplexed Diagnostics Demand Share Forecast, 2019-2026
10. Latin America Multiplexed Diagnostics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Multiplexed Diagnostics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Multiplexed Diagnostics Market Size and Volume Forecast by Application
10.4.1. Academic Research Institutes
10.4.2. Hospitals
10.4.3. Pharmaceuticals Companies
10.4.4. Clinical Research Organizations
10.4.5. Diagnostic Laboratories
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Multiplexed Diagnostics Market Size and Volume Forecast by Type
10.7.1. Very High Density
10.7.2. High Density
10.7.3. Medium Density
10.7.4. Low Density
10.7.5. Next Generation Sequencing Assays
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Multiplexed Diagnostics Demand Share Forecast, 2019-2026
11. Europe Multiplexed Diagnostics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Multiplexed Diagnostics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Multiplexed Diagnostics Market Size and Volume Forecast by Application
11.4.1. Academic Research Institutes
11.4.2. Hospitals
11.4.3. Pharmaceuticals Companies
11.4.4. Clinical Research Organizations
11.4.5. Diagnostic Laboratories
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Multiplexed Diagnostics Market Size and Volume Forecast by Type
11.7.1. Very High Density
117.2. High Density
11.7.3. Medium Density
11.7.4. Low Density
11.7.5. Next Generation Sequencing Assays
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Multiplexed Diagnostics Demand Share, 2019-2026
12. Asia Pacific Multiplexed Diagnostics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Multiplexed Diagnostics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Multiplexed Diagnostics Market Size and Volume Forecast by Application
12.4.1. Academic Research Institutes
12.4.2. Hospitals
12.4.3. Pharmaceuticals Companies
12.4.4. Clinical Research Organizations
12.4.5. Diagnostic Laboratories
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Multiplexed Diagnostics Market Size and Volume Forecast by Type
12.7.1. Very High Density
12.7.2. High Density
12.7.3. Medium Density
12.7.4. Low Density
12.7.5. Next Generation Sequencing Assays
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Multiplexed Diagnostics Demand Share, 2019-2026
13. Middle East & Africa Multiplexed Diagnostics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Multiplexed Diagnostics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Multiplexed Diagnostics Market Size and Volume Forecast by Application
13.4.1. Academic Research Institutes
13.4.2. Hospitals
13.4.3. Pharmaceuticals Companies
13.4.4. Clinical Research Organizations
13.4.5. Diagnostic Laboratories
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Multiplexed Diagnostics Market Size and Volume Forecast by Type
13.7.1. Very High Density
13.7.2. High Density
13.7.3. Medium Density
13.7.4. Low Density
13.7.5. Next Generation Sequencing Assays
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Multiplexed Diagnostics Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Multiplexed Diagnostics Market: Market Share Analysis
14.2. Multiplexed Diagnostics Distributors and Customers
14.3. Multiplexed Diagnostics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Agilent Technologies
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bio-Rad Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. BioMérieux
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Hoffmann-La Roche
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Illumina
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Luminex
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hologic
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Thermo Fisher Scientific
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Siemens Healthineers
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Abbott
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
